Skip to main content

#161909

Tera-2 Cell Line

Cat. #161909

Tera-2 Cell Line

Cat. #: 161909

Availability: 8-10 weeks

Organism: Human

Tissue: Lung

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Jorgen Fogh

Institute: Memorial Sloan-Kettering Cancer Center (MSK)

Primary Citation: Fogh et al. 1977. Journal of the National Cancer Institute. 59: 221-226. PMID: 327080.

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Tera-2 Cell Line
  • Cancer: Carcinoma
  • Organism: Human
  • Gender: Male
  • Tissue: Lung
  • Morphology: Epithelial
  • Growth properties: Adherent
  • Description: Human Carcinoma Cell Line Derived from a Lung Metastatic Site.
  • Application: 3D cell culture; Cancer research
  • Biosafety level: 1

Target Details

  • Target: Antigen expression: Blood Type A; Rh+

Applications

  • Application: 3D cell culture; Cancer research

Handling

  • Growth medium: McCoy's 5a Medium Modified supplemented with 15% FBS
  • Temperature: 37° C
  • Atmosphere: 95% Air, 5% CO2
  • Shipping conditions: Dry Ice
  • Storage medium: Culture medium 95%; DMSO, 5%
  • Storage conditions: Vapor phase of liquid nitrogen. Storage at -70° C will result in loss of viability.
  • Subculture routine: Subcultures are prepared by scraping. Remove spent medium, add fresh, dislodge cells from the floor of the flask, aspirate to disperse and dispense into new flasks. Subculture about once a week. Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended Medium Renewal: 2 to 3 times per week
  • Str profiling: Amelogenin: X,Y;CSF1PO: 10,12;D13S317: 13;D16S539: 11,12,13;D5S818: 9,12;D7S820: 10,12;TH01: 9.3;TPOX: 8;vWA: 18,19;D3S1358: 16;D21S11: 30,31;D18S51: 14;Penta_E: 5,14;Penta_D: 12,13;D8S1179: 13,15;FGA: 23;D19S433: 14,15.2;D2S1338: 22,25

References

  • Fogh J et al. 1977. Journal of the National Cancer Institute. 59: 221-226. PMID: 327080.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.